Gene Editing, CRISPR-Cas9, and the Future of Medicine

Jennifer Doudna, PhD
Co-discoverer of CRISPR-Cas9 Gene Editing

Every provider interested in providing the best care for their patients needs to understand CRISPR, it’s potential, and existing applications.

CRISPR-Cas9 is set to remake medicine, agriculture, and the future. It’s already showing promise for discovering new pharmaceuticals, as well as assessing and diagnosing diseases.

Forbes.com calls CRISPR-Cas9 “The Next Step in Human Evolution,” and “one of the greatest scientific revolutions of this generation.”

MIT Technology Review calls it “the biggest biotech discovery of the century.”

Learn from the co-discoverer of CRISPR-Cas9, Jennifer Doudna, PhD about the discovery, applications, and future of a technology that is changing the world as we know it.

The functions of CRISPR-Cas9

About the
Lindahl Lecture

Sten Lindahl addressing the Nobel assembly

The Lindahl Lecture was founded in 2013 in honor of Dr. Sten Lindahl, Chair Emeritus of the Nobel Committee in Physiology or Medicine, Professor Emeritus at Karolinska Institutet, and the kindest, most amazing man you’ll ever meet.

The Lindahl Lecture honors  mentorship as the foundation of innovation and scientific advancement.

In keeping with our mission, admission to the Lindahl Lectures are free to all students and researchers with interests in the sciences, innovation and clinical research.

Prior recipients

2017   Warren “Dr. Adventure” Zapol
Life at the Frontier

2016   Dr. Kevin J. Tracey
The Future of Bioelectronic Medicine

2015   Nobel Prize Winner
Dr. Bruce Beutler

2014   Dr. Robert Langer

2013   Dr. Sten Lindahl